Segments - Asia Pacific Beta-glucan Market by Category (Insoluble, Soluble, and Others), Applications (Healthcare & Dietary Supplements, Food & Beverage, and Others), Sources (Mushroom, Cereals, Yeast, and Others), and Region (India, Australia, Malaysia, China, Indonesia, Japan, and Rest of the Asia Pacific)–Industry Analysis, Growth, Share, Size, Trends, and Forecast 2023–2031
The Asia Pacific beta-glucan market size was USD XX Billion in 2022 and is likely to reach USD XX Billion by 2031, expanding at a CAGR of 5.75% during 2023–2031. Growth of the market is attributed to rapid urbanization, increasing overall efficiency & productivity for enterprises, rising awareness about health among consumers.
From the group of β-D-glucose polysaccharides the β-glucans are made. It is naturally found in the cell walls of fungi cereals, and bacteria. Depending on sources it shows different physicochemical properties significantly.
The Covid-19 pandemic affected the demand and supply of Asia Pacific beta-glucan market. Lockdown across the globe, supply chain disorders, and oscillating supply of raw materials forced manufacturers to shut down production leading to unfortunate decline in market growth. Launch of vaccines to combat the Covid-19 pandemic is expected to contribute to the market growth over the forecast period.
Increasing adoption of BYOD policies is projected to boost the market.
Rapid adoption of e-learning services is the major factor fueling the market.
Lack of awareness about the beta-glucan is projected to restrict the market expansion during the forecast period.
High price of the products is anticipated to hamper the market growth in the coming years.
R&D investment and technological advancement in beta-glucan market is projected to offer lucrative opportunities for the market players.
The report on the Asia Pacific beta-glucan market includes an assessment of the market, trends, segments, and regional markets. Overview and dynamics have also been included in the report.
Attributes |
Details |
Report Title |
Asia Pacific Beta-glucan Market–Industry Analysis, Growth, Share, Size, Trends, and Forecast |
Base Year |
2022 |
Historic Data |
2016-2021 |
Forecast Period |
2023-2031 |
Segmentation |
Category (Insoluble, Soluble, and Others), Applications (Healthcare & Dietary Supplements, Food & Beverage, and Others), Sources (Mushroom, Cereals, Yeast, and Others) |
Regional Scope |
India, Australia, Malaysia, China, Indonesia, Japan, and Rest of the Asia Pacific |
Report Coverage |
Company Share, Market Analysis and Size, Competitive Landscape, Growth Factors, and Trends, and Revenue Forecast |
Key Players covered in the Report |
Merck KGaA; Kemin Industries, Inc.; Koninklijke DSM N.V.; Tate & Lyle PLC; Associated British Foods Plc; Kerng Group plc.; and Angel Yeast Co. Ltd. |
On the basis of delivery modes, the Asia Pacific beta-glucan market is fragmented into insoluble, soluble, and others. The soluble segment accounts for a key share of the market. Growth of the market is attributed to increasing physical endurance & vitality of human body and increasing research & development activities in beta-glucan. However, the insoluble segment is anticipated to expand at a rapid pace during the forecast period due to increasing per capita income and rising demand for organic products.
Based on applications, the market is divided into healthcare & dietary supplements, food & beverage, and others. The corporate healthcare & dietary supplements segment accounts for a significant share of the market. Growth of the market is attributed to rising demand for soluble dietary fibers and increasing availability of resources. The food & beverages segment is anticipated to expand at a rapid pace during the forecast period due to factors such as rising investment by private sectors and rapidly changing lifestyle of people.
On the basis of sources, the Asia Pacific beta-glucan market is classified into mushroom, cereals, yeast, and others. The cereals segment accounts for a major share of the market. Growth of the market is attributed to increasing number of small & medium industries and growing demand for healthier alternatives. The mushroom segment is anticipated to expand at a rapid pace during the forecast period due to factors such as increasing healthcare expenditure, growing unit prices, and increasing applications of beta-glucan in healthcare industry.
On the basis of region, the Asia Pacific beta-glucan market is categorized as India, Australia, Malaysia, China, Indonesia, Japan, and Rest of the Asia Pacific. The market of Japan is estimated to expand at a high CAGR during the forecast period due to factors such as presence of major market players and increasing investment by private sector. The market of China is estimated to hold major market share due to rapidly growing number of working people, rapid economic growth, and rising demand for fibrous food.
The Asia Pacific beta-glucan market has been segmented on the basis of
Key players competing in the Asia Pacific beta-glucan market include Merck KGaA; Kemin Industries, Inc.; Koninklijke DSM N.V.; Tate & Lyle PLC; Associated British Foods Plc; Kerng Group plc.; and Angel Yeast Co. Ltd.
Some of these players are using several market strategies such as product launches, capacity expansion, merger, acquisitions, collaborations, and partnerships to enhance their market shares and to generate revenue and raise their production line of the business in the coming years.